Beijing, China

Lianyong Qiao

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lianyong Qiao. Retrieved from https://idiyas.com/inventor/lianyong-qiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lianyong Qiao: Innovator in Pharmaceutical Technology

Introduction

Lianyong Qiao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of targeted lipid compounds. His innovative work focuses on enhancing the efficiency and safety of drug delivery systems.

Latest Patents

Lianyong Qiao holds a patent for an "Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity." This patent describes a compound that is designed to improve the delivery of therapeutic or prophylactic agents while minimizing toxicity. The compound, along with its various forms, represents a significant advancement in pharmaceutical formulations.

Career Highlights

Lianyong Qiao is associated with Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. His role in the company has allowed him to apply his expertise in lipid compounds to real-world applications, contributing to the advancement of medical treatments.

Collaborations

Lianyong has collaborated with notable colleagues, including Shuai Wang and Kai Dong. Their combined efforts in research and development have furthered the understanding and application of lipid-based drug delivery systems.

Conclusion

Lianyong Qiao's innovative work in pharmaceutical technology exemplifies the impact of targeted drug delivery systems. His contributions continue to shape the future of medicine, enhancing the efficacy and safety of treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…